Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma

Blood

Volumn 91, Issue 12, 1998, Pages 4489-4495

  Tricot, G ^a   Gazitt, Y ^b   Leemhuis, T ^b   Jagannath, S ^b   Desikan, K R ^b   Siegel, D ^b   Fassas, A ^b   Tindle, S ^b   Nelson, J ^b   Juttner, C ^b   Tsukamoto, A ^b   Hallagan, J ^b   Atkinson, K ^b   Reading, C ^b   Hoffman, R ^b   Barlogie, B ^b  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN; THY 1 ANTIGEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTAMINATION; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURIFICATION;

EID: 0031838419     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4489     Document Type: Article

References (36)

1. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N, Payen C, Bataille R: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91, 1996
2. Barlogie B, Jagannath S, Vesole D, Naucke S, Cheson B, Mattox S, Bracy D, Salmon S, Jacobson J, Crowley J, Tricot G: Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 89:789, 1997
3. Tricot G, Barlogie B, Jagannath S, Vesole D, Naucke S, Tian E, Gazitt Y: Double autotransplants can induce molecular remissions (MCR) in newly diagnosed patients with multiple myeloma (MM). Blood 86:969a, 1995 (suppl 1)
4. Bjorkstrand B, Ljungman P, Bird JM, Samson D, Gahrton G: Double high-dose chemotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplant 15:367, 1995
5. Dreyfus F, Ribrag V, Leblond V, Ravaud P, Meile J, Wuarre MC, Pillier C, Boccaccio C, Varet B: Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma. Bone Marrow Transplant 15:707, 1995
6. + stem cells do not contain clonal myeloma cells. Blood 86:381, 1995
7. + cells to remove circulating tumor cells. Blood 87:1625, 1996
8. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marketing to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
9. Rill D, Santana V, Roberts M, Nilson T, Bowman L, Krance R, Heslop H, Moen C, Ihle J, Brenner K: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994
10. Reece DE, Barnett MJ, Connors JM, Klingemann G, O'Reilly SE, Shepherd JD, Sutherland HJ, Phillips GL: Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide. Bone Marrow Transplant 11:139, 1993
11. Anderson K, Barut B, Ritz J, Freedman A, Takworian T, Rabinowe S, Soiffer R, Heflin L, Coral F, Dear K, Mauch P, Nadler L: Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma. Blood 77:712, 1991
12. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994
13. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647, 1995
14. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
15. Civin CI, Trishcmann T, Kadan NS, Davis J, Noga S, Cohen K, Duffy B, Groenewegen I, Wiley J, Law P, Hardwick A, Oldham F, Gee A: Highly purified CD34-positive cells reconstitute hematopoiesis. J Clin Oncol 14:2224, 1996
16. Vescio R, Hong C, Cao J, Kim A, Schiller G, Lichtenstein A, Berenson R, Berenson J: The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994
17. + myeloma cells. Br J Haematol 93:613, 1996
18. Takishita M, Kosaka M, Goto T, Saito S: Cellular origin and extent of clonal involvement in multiple myeloma: Genetic and phenotypic studies. Br J Haematol 87:735, 1994
19. + cells in the blood of patients with multiple myeloma express clonotypic IgH sequences. Blood 84:385a, 1994 (suppl 1)
20. Spangrude GJ, Heimfeld S, Weissman IL: Purification and characterization of mouse hematopoietic stem cells. Science 241:58, 1988
21. - subpopulation from mobilized peripheral blood. Blood 85:368, 1995
22. Smith LG, Weissman IL, Heimfeld S: Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci USA 88:2788, 1991
23. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplant for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995
24. Law P, Schwartz GN, Alsop T, Haliber LM, Smith DM, Dooley DC: Removal of peripheral blood monocytes by phenylalanine methyl ester has no effect on the colony growth of hematopoietic progenitor cells. Int J Cell Cloning 7:100, 1989
25. Rosenfeld CS: Potential of phenylalanine methyl ester as a bone marrow purging agent. Blood 80:2401, 1992
26. Haas R, Witt B, Mohle R, Goldschmidt H, Hohaus S, Fruehauf S, Wannenmacher M, Hunstein W: Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 12:3754, 1995
27. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannemacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 12:3794, 1994
28. Craig W, Kay R, Culter R, Landsorp P: Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 177:1331, 1993
29. + hematopoietic progenitor cells. Blood 85:1936, 1995
30. 1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644, 1996
31. Gazitt Y, Tian E, Barlogie B, Reading C, Vesole D, Jagannath S, Schnell J, Hoffman R, Tricot G: Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after transplant after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 87:805, 1996
32. + stem cell content of peripheral blood collections. Exp Hematol 23:1619, 1995
33. + hematopoietic stem cells. Blood 83:3758, 1994
34. Moreau P, Fiere D, Bezwoda WR, Facon T, Altal M, Laporte JP, Colombat P, Haak HL, Monconduit M, Lockhorst H, Girault D, Harousseau JL: Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma. J Clin Oncol 15:660, 1997
35. Schwartz R: Jumping genes and the immunoglobulin V gene system. N Engl J Med 333:42, 1995
36. Mackall C, Fleisher T, Brown M, Magrath I, Shad A, Horowitz M, Wexler L, Adde M, McClure L, Gress R: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84:2221, 1994